COVID-19: the Heart and Other Issues

Overview

Journal Br J Cardiol

Specialty Cardiology & Vascular Diseases

Date 2022 Jun 24

PMID 35747083

Authors

Cormac T OConnor

David Mulcahy

Affiliations

Soon will be listed here.

Abstract

From the time that the first cases were reported from Wuhan, China on the 31 December 2019, our knowledge of the clinical and virological associations of the novel coronavirus (COVID-19) has been evolving at a rapid pace. On 18 May 2020, COVID-19 had caused over 4.82 million cases worldwide and resulted in 316,959 deaths. Whilst the primary focus of management for patients with COVID-19 remains close monitoring of respiratory function, there have been high levels of cardiac dysfunction in emerging cross-sectional and observational analyses, suggesting the need for heightened awareness in patients who may require cardiac input as part of a multidisciplinary approach. We review the current data on the association of COVID-19 and the heart.

References

Pollard A, Finn A, Curtis N . Non-specific effects of vaccines: plausible and potentially important, but implications uncertain. Arch Dis Child. 2017; 102(11):1077-1081. DOI: 10.1136/archdischild-2015-310282. View

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y . Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020; 395(10236):1569-1578. PMC: 7190303. DOI: 10.1016/S0140-6736(20)31022-9. View

Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P . Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(10237):1607-1608. PMC: 7204765. DOI: 10.1016/S0140-6736(20)31094-1. View

Zhang T, Wu Q, Zhang Z . Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Curr Biol. 2020; 30(7):1346-1351.e2. PMC: 7156161. DOI: 10.1016/j.cub.2020.03.022. View

Nemes E, Geldenhuys H, Rozot V, Rutkowski K, Ratangee F, Bilek N . Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. N Engl J Med. 2018; 379(2):138-149. PMC: 5937161. DOI: 10.1056/NEJMoa1714021. View

Oudit G, A Crackower M, Backx P, Penninger J . The role of ACE2 in cardiovascular physiology. Trends Cardiovasc Med. 2003; 13(3):93-101. DOI: 10.1016/s1050-1738(02)00233-5. View

Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B . A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005; 11(8):875-9. PMC: 7095783. DOI: 10.1038/nm1267. View

Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A . Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020; 382(24):2327-2336. PMC: 7169476. DOI: 10.1056/NEJMoa2007016. View

10.

Zwerling A, Behr M, Verma A, Brewer T, Menzies D, Pai M . The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011; 8(3):e1001012. PMC: 3062527. DOI: 10.1371/journal.pmed.1001012. View

11.

Gautret P, Lagier J, Parola P, Hoang V, Meddeb L, Mailhe M . RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949. PMC: 7102549. DOI: 10.1016/j.ijantimicag.2020.105949. View

12.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

13.

Arts R, Moorlag S, Novakovic B, Li Y, Wang S, Oosting M . BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe. 2018; 23(1):89-100.e5. DOI: 10.1016/j.chom.2017.12.010. View

14.

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

15.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

16.

Mercuro N, Yen C, Shim D, Maher T, McCoy C, Zimetbaum P . Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(9):1036-1041. PMC: 7195692. DOI: 10.1001/jamacardio.2020.1834. View

17.

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

18.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

19.

. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(14):422-426. PMC: 7147903. DOI: 10.15585/mmwr.mm6914e4. View

20.

Laird E, Rhodes J, Kenny R . Vitamin D and Inflammation: Potential Implications for Severity of Covid-19. Ir Med J. 2020; 113(5):81. View